Synthesizing and staining manganese oxide nanoparticles for cytotoxicity and cellular uptake investigation

For decades, contrast agents have been used to reduce longitudinal (T1) or transverse (T2) relaxation times. High toxicity of gadolinium-based contrast agents leads researchers to new T1 contrast agents. Manganese oxide (MnO) nanoparticle (NP) with the lower peril and good enough signal change abili...

Full description

Saved in:
Bibliographic Details
Published inBiochimica et biophysica acta Vol. 1840; no. 1; pp. 428 - 433
Main Authors Omid, Hamed, Oghabian, Mohammad Ali, Ahmadi, Reza, Shahbazi, Narges, Hosseini, Hamid Reza Madaah, Shanehsazzadeh, Saeed, Zangeneh, Rashin Namivandi
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.01.2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract For decades, contrast agents have been used to reduce longitudinal (T1) or transverse (T2) relaxation times. High toxicity of gadolinium-based contrast agents leads researchers to new T1 contrast agents. Manganese oxide (MnO) nanoparticle (NP) with the lower peril and good enough signal change ability has been offered as a new possibility for magnetic resonance imaging (MRI). The synthesized NPs were investigated for physicochemical and biological properties by X-ray diffraction, Fourier transform infrared spectroscopy, transmission electron microscope, dynamic light scattering (DLS), inductively coupled plasma, enzyme-linked immunosorbent assay, and 3T magnetic resonance imaging. Due to physical contact importance of T1 contrast agents with tissues' protons, extremely thin layer of the surfactant, less than 2nm, was coated on NPs for aqueous stabilizing. The hydrophilic gentisic acid with low Dalton, around 154, did that role truly. Moreover, decreasing NP size to 5nm which increases available surface for the proton relaxation is another important parameter to reach an appropriate longitudinal relaxation rate. The NPs didn't reveal any side effects on the cells, and cellular uptake was considerable. The synthesized NPs represented a promising result in comparison to clinical gadolinium chelates, due to higher r1 relaxivity and lower toxicity. In addition to considerable signal change and cellular uptake, Prussian blue was tried on MnO NPs for the initial time, which can be observed within cells by pale blue color. •We synthesized the stable nanocolloid of MnO nanoparticles.•The prepared nanoparticles have a wide improvement in r1 relaxivity compared to other available clinical T1 contrast agents.•Cellular uptake of nanoparticles was considerable with simple incubation with protamine sulfate as a transfection.•MnO nanoparticles were successfully stained by Prussian blue for the first time.
AbstractList For decades, contrast agents have been used to reduce longitudinal (T1) or transverse (T2) relaxation times. High toxicity of gadolinium-based contrast agents leads researchers to new T1 contrast agents. Manganese oxide (MnO) nanoparticle (NP) with the lower peril and good enough signal change ability has been offered as a new possibility for magnetic resonance imaging (MRI).The synthesized NPs were investigated for physicochemical and biological properties by X-ray diffraction, Fourier transform infrared spectroscopy, transmission electron microscope, dynamic light scattering (DLS), inductively coupled plasma, enzyme-linked immunosorbent assay, and 3T magnetic resonance imaging.Due to physical contact importance of T1 contrast agents with tissues' protons, extremely thin layer of the surfactant, less than 2nm, was coated on NPs for aqueous stabilizing. The hydrophilic gentisic acid with low Dalton, around 154, did that role truly. Moreover, decreasing NP size to 5nm which increases available surface for the proton relaxation is another important parameter to reach an appropriate longitudinal relaxation rate. The NPs didn't reveal any side effects on the cells, and cellular uptake was considerable.The synthesized NPs represented a promising result in comparison to clinical gadolinium chelates, due to higher r1 relaxivity and lower toxicity.In addition to considerable signal change and cellular uptake, Prussian blue was tried on MnO NPs for the initial time, which can be observed within cells by pale blue color.
For decades, contrast agents have been used to reduce longitudinal (T1) or transverse (T2) relaxation times. High toxicity of gadolinium-based contrast agents leads researchers to new T1 contrast agents. Manganese oxide (MnO) nanoparticle (NP) with the lower peril and good enough signal change ability has been offered as a new possibility for magnetic resonance imaging (MRI). The synthesized NPs were investigated for physicochemical and biological properties by X-ray diffraction, Fourier transform infrared spectroscopy, transmission electron microscope, dynamic light scattering (DLS), inductively coupled plasma, enzyme-linked immunosorbent assay, and 3T magnetic resonance imaging. Due to physical contact importance of T1 contrast agents with tissues' protons, extremely thin layer of the surfactant, less than 2nm, was coated on NPs for aqueous stabilizing. The hydrophilic gentisic acid with low Dalton, around 154, did that role truly. Moreover, decreasing NP size to 5nm which increases available surface for the proton relaxation is another important parameter to reach an appropriate longitudinal relaxation rate. The NPs didn't reveal any side effects on the cells, and cellular uptake was considerable. The synthesized NPs represented a promising result in comparison to clinical gadolinium chelates, due to higher r1 relaxivity and lower toxicity. In addition to considerable signal change and cellular uptake, Prussian blue was tried on MnO NPs for the initial time, which can be observed within cells by pale blue color.
For decades, contrast agents have been used to reduce longitudinal (T1) or transverse (T2) relaxation times. High toxicity of gadolinium-based contrast agents leads researchers to new T1 contrast agents. Manganese oxide (MnO) nanoparticle (NP) with the lower peril and good enough signal change ability has been offered as a new possibility for magnetic resonance imaging (MRI).BACKGROUNDFor decades, contrast agents have been used to reduce longitudinal (T1) or transverse (T2) relaxation times. High toxicity of gadolinium-based contrast agents leads researchers to new T1 contrast agents. Manganese oxide (MnO) nanoparticle (NP) with the lower peril and good enough signal change ability has been offered as a new possibility for magnetic resonance imaging (MRI).The synthesized NPs were investigated for physicochemical and biological properties by X-ray diffraction, Fourier transform infrared spectroscopy, transmission electron microscope, dynamic light scattering (DLS), inductively coupled plasma, enzyme-linked immunosorbent assay, and 3T magnetic resonance imaging.METHODSThe synthesized NPs were investigated for physicochemical and biological properties by X-ray diffraction, Fourier transform infrared spectroscopy, transmission electron microscope, dynamic light scattering (DLS), inductively coupled plasma, enzyme-linked immunosorbent assay, and 3T magnetic resonance imaging.Due to physical contact importance of T1 contrast agents with tissues' protons, extremely thin layer of the surfactant, less than 2nm, was coated on NPs for aqueous stabilizing. The hydrophilic gentisic acid with low Dalton, around 154, did that role truly. Moreover, decreasing NP size to 5nm which increases available surface for the proton relaxation is another important parameter to reach an appropriate longitudinal relaxation rate. The NPs didn't reveal any side effects on the cells, and cellular uptake was considerable.RESULTSDue to physical contact importance of T1 contrast agents with tissues' protons, extremely thin layer of the surfactant, less than 2nm, was coated on NPs for aqueous stabilizing. The hydrophilic gentisic acid with low Dalton, around 154, did that role truly. Moreover, decreasing NP size to 5nm which increases available surface for the proton relaxation is another important parameter to reach an appropriate longitudinal relaxation rate. The NPs didn't reveal any side effects on the cells, and cellular uptake was considerable.The synthesized NPs represented a promising result in comparison to clinical gadolinium chelates, due to higher r1 relaxivity and lower toxicity.CONCLUSIONSThe synthesized NPs represented a promising result in comparison to clinical gadolinium chelates, due to higher r1 relaxivity and lower toxicity.In addition to considerable signal change and cellular uptake, Prussian blue was tried on MnO NPs for the initial time, which can be observed within cells by pale blue color.GENERAL SIGNIFICANCEIn addition to considerable signal change and cellular uptake, Prussian blue was tried on MnO NPs for the initial time, which can be observed within cells by pale blue color.
For decades, contrast agents have been used to reduce longitudinal (T1) or transverse (T2) relaxation times. High toxicity of gadolinium-based contrast agents leads researchers to new T1 contrast agents. Manganese oxide (MnO) nanoparticle (NP) with the lower peril and good enough signal change ability has been offered as a new possibility for magnetic resonance imaging (MRI). The synthesized NPs were investigated for physicochemical and biological properties by X-ray diffraction, Fourier transform infrared spectroscopy, transmission electron microscope, dynamic light scattering (DLS), inductively coupled plasma, enzyme-linked immunosorbent assay, and 3T magnetic resonance imaging. Due to physical contact importance of T1 contrast agents with tissues' protons, extremely thin layer of the surfactant, less than 2nm, was coated on NPs for aqueous stabilizing. The hydrophilic gentisic acid with low Dalton, around 154, did that role truly. Moreover, decreasing NP size to 5nm which increases available surface for the proton relaxation is another important parameter to reach an appropriate longitudinal relaxation rate. The NPs didn't reveal any side effects on the cells, and cellular uptake was considerable. The synthesized NPs represented a promising result in comparison to clinical gadolinium chelates, due to higher r1 relaxivity and lower toxicity. In addition to considerable signal change and cellular uptake, Prussian blue was tried on MnO NPs for the initial time, which can be observed within cells by pale blue color. •We synthesized the stable nanocolloid of MnO nanoparticles.•The prepared nanoparticles have a wide improvement in r1 relaxivity compared to other available clinical T1 contrast agents.•Cellular uptake of nanoparticles was considerable with simple incubation with protamine sulfate as a transfection.•MnO nanoparticles were successfully stained by Prussian blue for the first time.
Author Hosseini, Hamid Reza Madaah
Omid, Hamed
Ahmadi, Reza
Shanehsazzadeh, Saeed
Zangeneh, Rashin Namivandi
Shahbazi, Narges
Oghabian, Mohammad Ali
Author_xml – sequence: 1
  givenname: Hamed
  surname: Omid
  fullname: Omid, Hamed
  email: h_omid@alum.sharif.edu
  organization: Department of Materials Science and Engineering, Sharif University of Technology, Azadi Ave., 14588-9694 Tehran, Iran
– sequence: 2
  givenname: Mohammad Ali
  surname: Oghabian
  fullname: Oghabian, Mohammad Ali
  organization: Research Center for Science & Technology in Medicine, Imam Khomeini Hospital, Tehran, Iran
– sequence: 3
  givenname: Reza
  surname: Ahmadi
  fullname: Ahmadi, Reza
  organization: Department of Materials Science and Engineering, Sharif University of Technology, Azadi Ave., 14588-9694 Tehran, Iran
– sequence: 4
  givenname: Narges
  surname: Shahbazi
  fullname: Shahbazi, Narges
  organization: Department of Nanobiotechnology, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran
– sequence: 5
  givenname: Hamid Reza Madaah
  surname: Hosseini
  fullname: Hosseini, Hamid Reza Madaah
  organization: Department of Materials Science and Engineering, Sharif University of Technology, Azadi Ave., 14588-9694 Tehran, Iran
– sequence: 6
  givenname: Saeed
  surname: Shanehsazzadeh
  fullname: Shanehsazzadeh, Saeed
  organization: Department of Medical Physics, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
– sequence: 7
  givenname: Rashin Namivandi
  surname: Zangeneh
  fullname: Zangeneh, Rashin Namivandi
  organization: School of Chemistry, University College of Science, University of Tehran, P.O. Box 14155-6455, Tehran, Iran
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24112973$$D View this record in MEDLINE/PubMed
BookMark eNqFUctuFDEQtFAQ2QT-AKE5cpnFj3nYHJBQxEuKxCHhbLU9PYuXWXuxPVGWr8eTTS45JL5Y7q6qdledkRMfPBLyltE1o6z7sF0bAxv0a06ZKKU1pewFWTHZ81pS2p2QFRW0qRvWtafkLKUtLadV7StyyhvGuOrFimyvDj7_xuT-Ob-pwA9VyuD88tiB34DHhFW4dQNWHnzYQ8zOTpiqMcTKHnLIpWldPtxxLU7TPEGs5n2GP1g5f4Mpuw1kF_xr8nKEKeGb-_uc_Pr65frie33589uPi8-XtRWqzXUvpOnRgBWyA0WlVKjGkTUcRqPkULYdQTUtM4ZS5ENptAMKZQAGjgiNOCfvj7r7GP7OZb7eubT8rCwT5qR5sYFTJXr5LJQ1XU-7VsoF-u4eOpsdDnof3Q7iQT9YWQAfjwAbQ0oRR11suVs8R3CTZlQvuemtPuaml9yWasmtkJtH5Af9Z2ifjjQsft44jDpZh97i4CLarIfgnhb4DwSptdg
CitedBy_id crossref_primary_10_1016_j_ijbiomac_2018_11_191
crossref_primary_10_3389_fmicb_2020_588326
crossref_primary_10_3390_antiox12020393
crossref_primary_10_3390_jcs8020063
crossref_primary_10_1002_adbi_201800086
crossref_primary_10_1002_cmmi_1627
crossref_primary_10_1007_s00253_015_6559_4
crossref_primary_10_1007_s10967_015_4251_x
crossref_primary_10_1080_14686996_2021_1927175
crossref_primary_10_3390_nano11020361
crossref_primary_10_1016_j_jnoncrysol_2023_122656
crossref_primary_10_1049_iet_nbt_2014_0051
crossref_primary_10_1080_10667857_2020_1761660
crossref_primary_10_1021_acs_bioconjchem_9b00499
crossref_primary_10_1016_j_jhazmat_2023_131657
crossref_primary_10_1016_j_msec_2021_112575
crossref_primary_10_1088_2053_1591_ab62f3
crossref_primary_10_1002_adfm_201907066
crossref_primary_10_1007_s12149_015_0997_z
crossref_primary_10_1039_D3TB00779K
crossref_primary_10_1016_j_inoche_2023_111306
crossref_primary_10_1002_slct_201901760
crossref_primary_10_1007_s00723_015_0667_2
Cites_doi 10.1016/j.bbagen.2013.01.021
10.1056/NEJM197208312870903
10.1021/ja1084095
10.1038/nnano.2012.237
10.1002/nbm.940
10.1016/j.bbagen.2010.03.001
10.1021/nn1019779
10.1002/anie.200604775
10.1016/j.bbagen.2004.03.007
10.1248/cpb.44.2305
10.1016/j.pdpdt.2011.08.004
10.1021/ja0362656
10.1103/PhysRevB.75.134423
10.1016/j.ijpharm.2012.04.080
10.1016/j.sbi.2003.10.010
10.1016/j.addr.2010.05.006
10.1021/am100641z
10.1021/nn101277w
10.4103/0971-6203.106603
10.1016/j.bbr.2010.08.007
10.1016/j.mri.2005.12.017
10.1002/nbm.945
10.1016/j.biomaterials.2012.01.062
10.1186/1477-3155-8-25
10.1039/c0jm00174k
10.1039/b615972a
10.1021/cr100440g
ContentType Journal Article
Copyright 2013 Elsevier B.V.
2013.
Copyright_xml – notice: 2013 Elsevier B.V.
– notice: 2013.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
DOI 10.1016/j.bbagen.2013.10.001
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList AGRICOLA
MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Biology
EISSN 1872-8006
EndPage 433
ExternalDocumentID 24112973
10_1016_j_bbagen_2013_10_001
S0304416513004406
Genre Journal Article
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
23N
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXUO
ABEFU
ABFNM
ABGSF
ABMAC
ABUDA
ABXDB
ABYKQ
ACDAQ
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
ADUVX
AEBSH
AEHWI
AEKER
AFKWA
AFTJW
AFXIZ
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
CS3
DOVZS
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HLW
HVGLF
HZ~
IHE
J1W
KOM
LX3
M41
MO0
N9A
O-L
O9-
OAUVE
OHT
OZT
P-8
P-9
PC.
Q38
R2-
ROL
RPZ
SBG
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SSU
SSZ
T5K
UQL
WH7
WUQ
XJT
XPP
~G-
AAHBH
AATTM
AAXKI
AAYWO
AAYXX
ABWVN
ACRPL
ACVFH
ADCNI
ADNMO
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRNS
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
BNPGV
CITATION
SSH
-~X
.55
.GJ
AAYJJ
ABJNI
AFFNX
AI.
CGR
CUY
CVF
ECM
EIF
F5P
H~9
K-O
MVM
NPM
RIG
TWZ
UHS
VH1
X7M
Y6R
YYP
ZE2
ZGI
~KM
7X8
7S9
L.6
ID FETCH-LOGICAL-c395t-738b7ebac386a90889e9ff142afb98d201fa9451bb00e2d1425de39baad2eea43
IEDL.DBID .~1
ISSN 0304-4165
0006-3002
IngestDate Fri Jul 11 11:02:20 EDT 2025
Fri Jul 11 10:06:06 EDT 2025
Mon Jul 21 05:36:09 EDT 2025
Thu Apr 24 22:53:14 EDT 2025
Tue Jul 01 00:22:02 EDT 2025
Fri Feb 23 02:32:43 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Manganese oxide nanoparticle
Cell uptake
Cytotoxicity
MRI contrast agent
Prussian blue staining
Language English
License 2013.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c395t-738b7ebac386a90889e9ff142afb98d201fa9451bb00e2d1425de39baad2eea43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 24112973
PQID 1467065888
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_2000209378
proquest_miscellaneous_1467065888
pubmed_primary_24112973
crossref_citationtrail_10_1016_j_bbagen_2013_10_001
crossref_primary_10_1016_j_bbagen_2013_10_001
elsevier_sciencedirect_doi_10_1016_j_bbagen_2013_10_001
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate January 2014
2014-01-00
2014-Jan
20140101
PublicationDateYYYYMMDD 2014-01-01
PublicationDate_xml – month: 01
  year: 2014
  text: January 2014
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Biochimica et biophysica acta
PublicationTitleAlternate Biochim Biophys Acta
PublicationYear 2014
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Koretsky, Silva (bb0010) 2004; 17
Chen, Dong, Shi, Zhao, Hua, Gao, Ruan, Yan (bb0110) 2007; 17
Morales, Skomski, Fritz, Shelburne, Shield, Yin, O'Brien, Leslie-Pelecky (bb0035) 2007; 75
Kim, Momin, Choi, Yuan, Zaidi, Kim, Park, Lee, McMahon, Quinones-Hinojosa, Bulte, Hyeon, Gilad (bb0135) 2011; 133
Huff, Balch, Kelly (bb0125) 2003; 13
Tu, Chou, Chen, Chang, Shen, Yeh (bb0105) 2004; 1672
Levy, Tsuchiya (bb0060) 1972; 287
Silva, Lee, Aoki, Koretsky (bb0015) 2004; 17
Zhang, Gong, Zhang, Yang, Wang, Gu (bb0065) 2010; 20
Bennewitz, Lobo, Nkansah, Ulas, Brudvig, Shapiro (bb0045) 2011; 5
Masoudi, Madaah Hosseini, Shokrgozar, Ahmadi, Oghabian (bb0080) 2012; 433
Lee, Chen, Dodd, Bouraoud, Koretsky, Krishnan (bb0030) 2012; 33
Shanehsazzadeh, Oghabian, Allen, Amanlou, Masoudi, Daha (bb0070) 2013; 38
Jackson, Hussey, Jansen, Merrifield, Marshall, MacLullich, Yau, Bast (bb0005) 2011; 216
Liu, Hitchens, Ye, Wu, Barbe, Prior, Li, Yeh, Foley, Bain, Ho (bb0090) 2013; 1830
Hou, Liu, Chen, Gu, Wang (bb0075) 2010; 8
Montazerabadi, Sazgarnia, Bahreyni-Toosi, Ahmadi, Shakeri-Zadeh, Aledavood (bb0100) 2012; 9
Baek, Park, Xu, Kattel, Kim, Lee, Patel, Lee, Chang, Kim, Bae, Chae, Lee (bb0050) 2010; 2
Yin, O'Brien (bb0025) 2003; 125
Mino, Yamada, Takeda, Nagasawa (bb0020) 1996; 44
Mahmoudi, Sant, Wang, Laurent, Sen (bb0120) 2011; 63
Mahmoudi, Lynch, Ejtehadi, Monopoli, Bombelli, Laurent (bb0055) 2011; 111
Salvati, Pitek, Monopoli, Prapainop, Bombelli, Hristov, Kelly, Åberg, Mahon, Dawson (bb0130) 2013; 8
Na, Lee, An, Park, Park, Lee, Nam, Kim, Kim, Kim, Lim, Kim, Kim, Hyeon (bb0040) 2007; 46
Ju, Teng, Zhang, Ma, Chen, Ni (bb0085) 2006; 24
Jiang, Rocker, Hafner, Brandholt, Dorlich, Nienhaus (bb0115) 2010; 4
Watt, Hilton, Graff (bb0095) 2010; 1800
Tu (10.1016/j.bbagen.2013.10.001_bb0105) 2004; 1672
Chen (10.1016/j.bbagen.2013.10.001_bb0110) 2007; 17
Huff (10.1016/j.bbagen.2013.10.001_bb0125) 2003; 13
Silva (10.1016/j.bbagen.2013.10.001_bb0015) 2004; 17
Hou (10.1016/j.bbagen.2013.10.001_bb0075) 2010; 8
Morales (10.1016/j.bbagen.2013.10.001_bb0035) 2007; 75
Jiang (10.1016/j.bbagen.2013.10.001_bb0115) 2010; 4
Mahmoudi (10.1016/j.bbagen.2013.10.001_bb0055) 2011; 111
Zhang (10.1016/j.bbagen.2013.10.001_bb0065) 2010; 20
Liu (10.1016/j.bbagen.2013.10.001_bb0090) 2013; 1830
Jackson (10.1016/j.bbagen.2013.10.001_bb0005) 2011; 216
Montazerabadi (10.1016/j.bbagen.2013.10.001_bb0100) 2012; 9
Levy (10.1016/j.bbagen.2013.10.001_bb0060) 1972; 287
Masoudi (10.1016/j.bbagen.2013.10.001_bb0080) 2012; 433
Bennewitz (10.1016/j.bbagen.2013.10.001_bb0045) 2011; 5
Kim (10.1016/j.bbagen.2013.10.001_bb0135) 2011; 133
Mino (10.1016/j.bbagen.2013.10.001_bb0020) 1996; 44
Lee (10.1016/j.bbagen.2013.10.001_bb0030) 2012; 33
Koretsky (10.1016/j.bbagen.2013.10.001_bb0010) 2004; 17
Na (10.1016/j.bbagen.2013.10.001_bb0040) 2007; 46
Ju (10.1016/j.bbagen.2013.10.001_bb0085) 2006; 24
Yin (10.1016/j.bbagen.2013.10.001_bb0025) 2003; 125
Mahmoudi (10.1016/j.bbagen.2013.10.001_bb0120) 2011; 63
Baek (10.1016/j.bbagen.2013.10.001_bb0050) 2010; 2
Shanehsazzadeh (10.1016/j.bbagen.2013.10.001_bb0070) 2013; 38
Salvati (10.1016/j.bbagen.2013.10.001_bb0130) 2013; 8
Watt (10.1016/j.bbagen.2013.10.001_bb0095) 2010; 1800
References_xml – volume: 75
  start-page: 134423
  year: 2007
  ident: bb0035
  article-title: Surface anisotropy and magnetic freezing of MnO nanoparticles
  publication-title: Phys. Rev. B
– volume: 287
  start-page: 430
  year: 1972
  end-page: 432
  ident: bb0060
  article-title: Salicylate accumulation kinetics in man
  publication-title: N. Engl. J. Med.
– volume: 13
  start-page: 674
  year: 2003
  end-page: 682
  ident: bb0125
  article-title: Pathological and functional amyloid formation orchestrated by the secretory pathway
  publication-title: Curr. Opin. Struct. Biol.
– volume: 111
  start-page: 5610
  year: 2011
  end-page: 5637
  ident: bb0055
  article-title: Protein-nanoparticle interactions: opportunities and challenges
  publication-title: Chem. Rev.
– volume: 9
  start-page: 46
  year: 2012
  end-page: 51
  ident: bb0100
  article-title: Mitoxantrone as a prospective photosensitizer for photodynamic therapy of breast cancer
  publication-title: Photodiagn. Photodyn. Ther.
– volume: 4
  start-page: 6787
  year: 2010
  end-page: 6797
  ident: bb0115
  article-title: Endo- and exocytosis of zwitterionic quantum dot nanoparticles by live HeLa cells
  publication-title: ACS Nano
– volume: 133
  start-page: 2955
  year: 2011
  end-page: 2961
  ident: bb0135
  article-title: Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T 1 contrast agents for labeling and MRI tracking of adipose-derived mesenchymal stem cells
  publication-title: J. Am. Chem. Soc.
– volume: 1830
  start-page: 3447
  year: 2013
  end-page: 3453
  ident: bb0090
  article-title: Decreased reticuloendothelial system clearance and increased blood half-life and immune cell labeling for nano- and micron-sized superparamagnetic iron-oxide particles upon pre-treatment with Intralipid
  publication-title: Biochim. Biophys. Acta Gen. Subj.
– volume: 433
  start-page: 129
  year: 2012
  end-page: 141
  ident: bb0080
  article-title: The effect of poly(ethylene glycol) coating on colloidal stability of superparamagnetic iron oxide nanoparticles as potential MRI contrast agent
  publication-title: Int. J. Pharm.
– volume: 24
  start-page: 611
  year: 2006
  end-page: 617
  ident: bb0085
  article-title: In vitro labeling and MRI of mesenchymal stem cells from human umbilical cord blood
  publication-title: Magn. Reson. Imaging
– volume: 17
  start-page: 527
  year: 2004
  end-page: 531
  ident: bb0010
  article-title: Manganese-enhanced magnetic resonance imaging
  publication-title: NMR Biomed.
– volume: 33
  start-page: 3560
  year: 2012
  end-page: 3567
  ident: bb0030
  article-title: The use of silica coated MnO nanoparticles to control MRI relaxivity in response to specific physiological changes
  publication-title: Biomaterials
– volume: 5
  start-page: 3438
  year: 2011
  end-page: 3446
  ident: bb0045
  article-title: Biocompatible and pH sensitive PLGA encapsulated MnO nanocrystals for molecular and cellular MRI
  publication-title: ACS Nano
– volume: 8
  start-page: 25
  year: 2010
  ident: bb0075
  article-title: Manufacture of IRDye800CW-coupled Fe3O4 nanoparticles and their applications in cell labeling and in vivo imaging
  publication-title: J. Nanobiotechnol.
– volume: 46
  start-page: 5397
  year: 2007
  end-page: 5401
  ident: bb0040
  article-title: Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles
  publication-title: Angew. Chem. Int. Ed.
– volume: 2
  start-page: 2949
  year: 2010
  end-page: 2955
  ident: bb0050
  article-title: Water-soluble MnO nanocolloid for a molecular T 1 MR imaging: a facile one-pot synthesis, in vivo T 1 MR images, and account for relaxivities
  publication-title: ACS Appl. Mater. Interfaces
– volume: 216
  start-page: 293
  year: 2011
  end-page: 300
  ident: bb0005
  article-title: Manganese-enhanced magnetic resonance imaging (MEMRI) of rat brain after systemic administration of MnCl2: hippocampal signal enhancement without disruption of hippocampus-dependent behavior
  publication-title: Behav. Brain Res.
– volume: 17
  start-page: 532
  year: 2004
  end-page: 543
  ident: bb0015
  article-title: Manganese-enhanced magnetic resonance imaging (MEMRI): methodological and practical considerations
  publication-title: NMR Biomed.
– volume: 44
  start-page: 2305
  year: 1996
  end-page: 2308
  ident: bb0020
  article-title: Metal-containing components in medicinal plants. III. Manganese-containing components in
  publication-title: Chem. Pharm. Bull. (Tokyo)
– volume: 125
  start-page: 10180
  year: 2003
  end-page: 10181
  ident: bb0025
  article-title: Synthesis of monodisperse nanocrystals of manganese oxides
  publication-title: J. Am. Chem. Soc.
– volume: 17
  start-page: 855
  year: 2007
  end-page: 860
  ident: bb0110
  article-title: Templated synthesis of hierarchically porous manganese oxide with a crystalline nanorod framework and its high electrochemical performance
  publication-title: J. Mater. Chem.
– volume: 1800
  start-page: 745
  year: 2010
  end-page: 759
  ident: bb0095
  article-title: Oxido-reduction is not the only mechanism allowing ions to traverse the ferritin protein shell
  publication-title: Biochim. Biophys. Acta Gen. Subj.
– volume: 1672
  start-page: 148
  year: 2004
  end-page: 156
  ident: bb0105
  article-title: Characterization of the cytotoxic mechanism of Mana-Hox, an analog of manzamine alkaloids
  publication-title: Biochim. Biophys. Acta Gen. Subj.
– volume: 38
  start-page: 34
  year: 2013
  end-page: 40
  ident: bb0070
  article-title: Evaluating the effect of ultrasmall superparamagnetic iron oxide nanoparticles for a long-term magnetic cell labeling
  publication-title: J. Med. Phys.
– volume: 8
  start-page: 137
  year: 2013
  end-page: 143
  ident: bb0130
  article-title: Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface
  publication-title: Nat. Nanotechnol.
– volume: 20
  start-page: 5110
  year: 2010
  end-page: 5116
  ident: bb0065
  article-title: Prussian blue modified iron oxide magnetic nanoparticles and their high peroxidase-like activity
  publication-title: J. Mater. Chem.
– volume: 63
  start-page: 24
  year: 2011
  end-page: 46
  ident: bb0120
  article-title: Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy
  publication-title: Adv. Drug Deliv. Rev.
– volume: 1830
  start-page: 3447
  year: 2013
  ident: 10.1016/j.bbagen.2013.10.001_bb0090
  article-title: Decreased reticuloendothelial system clearance and increased blood half-life and immune cell labeling for nano- and micron-sized superparamagnetic iron-oxide particles upon pre-treatment with Intralipid
  publication-title: Biochim. Biophys. Acta Gen. Subj.
  doi: 10.1016/j.bbagen.2013.01.021
– volume: 287
  start-page: 430
  year: 1972
  ident: 10.1016/j.bbagen.2013.10.001_bb0060
  article-title: Salicylate accumulation kinetics in man
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM197208312870903
– volume: 133
  start-page: 2955
  year: 2011
  ident: 10.1016/j.bbagen.2013.10.001_bb0135
  article-title: Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T 1 contrast agents for labeling and MRI tracking of adipose-derived mesenchymal stem cells
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja1084095
– volume: 8
  start-page: 137
  year: 2013
  ident: 10.1016/j.bbagen.2013.10.001_bb0130
  article-title: Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface
  publication-title: Nat. Nanotechnol.
  doi: 10.1038/nnano.2012.237
– volume: 17
  start-page: 527
  year: 2004
  ident: 10.1016/j.bbagen.2013.10.001_bb0010
  article-title: Manganese-enhanced magnetic resonance imaging
  publication-title: NMR Biomed.
  doi: 10.1002/nbm.940
– volume: 1800
  start-page: 745
  year: 2010
  ident: 10.1016/j.bbagen.2013.10.001_bb0095
  article-title: Oxido-reduction is not the only mechanism allowing ions to traverse the ferritin protein shell
  publication-title: Biochim. Biophys. Acta Gen. Subj.
  doi: 10.1016/j.bbagen.2010.03.001
– volume: 5
  start-page: 3438
  year: 2011
  ident: 10.1016/j.bbagen.2013.10.001_bb0045
  article-title: Biocompatible and pH sensitive PLGA encapsulated MnO nanocrystals for molecular and cellular MRI
  publication-title: ACS Nano
  doi: 10.1021/nn1019779
– volume: 46
  start-page: 5397
  year: 2007
  ident: 10.1016/j.bbagen.2013.10.001_bb0040
  article-title: Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles
  publication-title: Angew. Chem. Int. Ed.
  doi: 10.1002/anie.200604775
– volume: 1672
  start-page: 148
  year: 2004
  ident: 10.1016/j.bbagen.2013.10.001_bb0105
  article-title: Characterization of the cytotoxic mechanism of Mana-Hox, an analog of manzamine alkaloids
  publication-title: Biochim. Biophys. Acta Gen. Subj.
  doi: 10.1016/j.bbagen.2004.03.007
– volume: 44
  start-page: 2305
  year: 1996
  ident: 10.1016/j.bbagen.2013.10.001_bb0020
  article-title: Metal-containing components in medicinal plants. III. Manganese-containing components in Theae folium as oral magnetic resonance imaging contrast materials
  publication-title: Chem. Pharm. Bull. (Tokyo)
  doi: 10.1248/cpb.44.2305
– volume: 9
  start-page: 46
  year: 2012
  ident: 10.1016/j.bbagen.2013.10.001_bb0100
  article-title: Mitoxantrone as a prospective photosensitizer for photodynamic therapy of breast cancer
  publication-title: Photodiagn. Photodyn. Ther.
  doi: 10.1016/j.pdpdt.2011.08.004
– volume: 125
  start-page: 10180
  year: 2003
  ident: 10.1016/j.bbagen.2013.10.001_bb0025
  article-title: Synthesis of monodisperse nanocrystals of manganese oxides
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja0362656
– volume: 75
  start-page: 134423
  year: 2007
  ident: 10.1016/j.bbagen.2013.10.001_bb0035
  article-title: Surface anisotropy and magnetic freezing of MnO nanoparticles
  publication-title: Phys. Rev. B
  doi: 10.1103/PhysRevB.75.134423
– volume: 433
  start-page: 129
  year: 2012
  ident: 10.1016/j.bbagen.2013.10.001_bb0080
  article-title: The effect of poly(ethylene glycol) coating on colloidal stability of superparamagnetic iron oxide nanoparticles as potential MRI contrast agent
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2012.04.080
– volume: 13
  start-page: 674
  year: 2003
  ident: 10.1016/j.bbagen.2013.10.001_bb0125
  article-title: Pathological and functional amyloid formation orchestrated by the secretory pathway
  publication-title: Curr. Opin. Struct. Biol.
  doi: 10.1016/j.sbi.2003.10.010
– volume: 63
  start-page: 24
  year: 2011
  ident: 10.1016/j.bbagen.2013.10.001_bb0120
  article-title: Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/j.addr.2010.05.006
– volume: 2
  start-page: 2949
  year: 2010
  ident: 10.1016/j.bbagen.2013.10.001_bb0050
  article-title: Water-soluble MnO nanocolloid for a molecular T 1 MR imaging: a facile one-pot synthesis, in vivo T 1 MR images, and account for relaxivities
  publication-title: ACS Appl. Mater. Interfaces
  doi: 10.1021/am100641z
– volume: 4
  start-page: 6787
  year: 2010
  ident: 10.1016/j.bbagen.2013.10.001_bb0115
  article-title: Endo- and exocytosis of zwitterionic quantum dot nanoparticles by live HeLa cells
  publication-title: ACS Nano
  doi: 10.1021/nn101277w
– volume: 38
  start-page: 34
  year: 2013
  ident: 10.1016/j.bbagen.2013.10.001_bb0070
  article-title: Evaluating the effect of ultrasmall superparamagnetic iron oxide nanoparticles for a long-term magnetic cell labeling
  publication-title: J. Med. Phys.
  doi: 10.4103/0971-6203.106603
– volume: 216
  start-page: 293
  year: 2011
  ident: 10.1016/j.bbagen.2013.10.001_bb0005
  article-title: Manganese-enhanced magnetic resonance imaging (MEMRI) of rat brain after systemic administration of MnCl2: hippocampal signal enhancement without disruption of hippocampus-dependent behavior
  publication-title: Behav. Brain Res.
  doi: 10.1016/j.bbr.2010.08.007
– volume: 24
  start-page: 611
  year: 2006
  ident: 10.1016/j.bbagen.2013.10.001_bb0085
  article-title: In vitro labeling and MRI of mesenchymal stem cells from human umbilical cord blood
  publication-title: Magn. Reson. Imaging
  doi: 10.1016/j.mri.2005.12.017
– volume: 17
  start-page: 532
  year: 2004
  ident: 10.1016/j.bbagen.2013.10.001_bb0015
  article-title: Manganese-enhanced magnetic resonance imaging (MEMRI): methodological and practical considerations
  publication-title: NMR Biomed.
  doi: 10.1002/nbm.945
– volume: 33
  start-page: 3560
  year: 2012
  ident: 10.1016/j.bbagen.2013.10.001_bb0030
  article-title: The use of silica coated MnO nanoparticles to control MRI relaxivity in response to specific physiological changes
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2012.01.062
– volume: 8
  start-page: 25
  year: 2010
  ident: 10.1016/j.bbagen.2013.10.001_bb0075
  article-title: Manufacture of IRDye800CW-coupled Fe3O4 nanoparticles and their applications in cell labeling and in vivo imaging
  publication-title: J. Nanobiotechnol.
  doi: 10.1186/1477-3155-8-25
– volume: 20
  start-page: 5110
  year: 2010
  ident: 10.1016/j.bbagen.2013.10.001_bb0065
  article-title: Prussian blue modified iron oxide magnetic nanoparticles and their high peroxidase-like activity
  publication-title: J. Mater. Chem.
  doi: 10.1039/c0jm00174k
– volume: 17
  start-page: 855
  year: 2007
  ident: 10.1016/j.bbagen.2013.10.001_bb0110
  article-title: Templated synthesis of hierarchically porous manganese oxide with a crystalline nanorod framework and its high electrochemical performance
  publication-title: J. Mater. Chem.
  doi: 10.1039/b615972a
– volume: 111
  start-page: 5610
  year: 2011
  ident: 10.1016/j.bbagen.2013.10.001_bb0055
  article-title: Protein-nanoparticle interactions: opportunities and challenges
  publication-title: Chem. Rev.
  doi: 10.1021/cr100440g
SSID ssj0000595
ssj0025309
Score 2.2391677
Snippet For decades, contrast agents have been used to reduce longitudinal (T1) or transverse (T2) relaxation times. High toxicity of gadolinium-based contrast agents...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 428
SubjectTerms 2,5-dihydroxybenzoic acid
adverse effects
Apoptosis
Cell Proliferation
Cell uptake
chelates
color
Cytotoxicity
Enzyme-Linked Immunosorbent Assay
Fourier transform infrared spectroscopy
gadolinium
Gentisates - chemistry
HeLa Cells
Humans
hydrophilicity
light scattering
Magnetic Resonance Imaging
Manganese Compounds - chemistry
Manganese oxide nanoparticle
manganese oxides
MRI contrast agent
nanoparticles
Nanoparticles - administration & dosage
Nanoparticles - chemistry
Oxides - chemistry
Particle Size
protons
Prussian blue staining
Spectrophotometry, Atomic
Spectroscopy, Fourier Transform Infrared
staining
surfactants
tissues
transmission electron microscopes
X-Ray Diffraction
Title Synthesizing and staining manganese oxide nanoparticles for cytotoxicity and cellular uptake investigation
URI https://dx.doi.org/10.1016/j.bbagen.2013.10.001
https://www.ncbi.nlm.nih.gov/pubmed/24112973
https://www.proquest.com/docview/1467065888
https://www.proquest.com/docview/2000209378
Volume 1840
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEA6LInoR32-J4LUuTdJtepRFWV3w4AO9lSRNpT7SRbvgevC3O5O2Lh4WwVNJM4GQSTJfMl9mCDmWMpeGKVhIxphAhJYFKsx5wE3GdM4FBi1CtsVVb3AnLh-ihw7pt29hkFbZ7P31nu536-ZPtxnN7qgoujfo1AM4EaFDRggfdluIGGf5ydeU5gHwIao9CSJA6fb5nOd4aQ2LFqOghvzEc7zCWeZpFvz0Zuh8hSw3-JGe1l1cJR3r1shCnVFyskYW-20Ct3XydDNxAO_ei08wT1S5jPq3Ulh4Ve5RYe5JWn4UmaVOOTg8Nxw5CjiWmklVVlBpAKX7tnjDj5RVOh5V6tnSYhqgo3Qb5O787LY_CJrUCoHhSVQFMZc6tloZLnvKU51skuehYCrXicxgQHKViCjUsCoty6AiyixPtFIZs1YJvknmXOnsNqFMA6qRIpMYSZ2ZUMex5hh2j3MjDOM7hLcjmpom7jimv3hJW4LZU1rrIUU94F_Qww4JflqN6rgbf8jHrbLSX_MnBdPwR8ujVrcpKAhHExRQjt_xVIROYCnlbBnmfbmA8UBmq54YP_0FcBRiarDdf_dtjyxBSdRXPvtkrnob2wMAQZU-9LP8kMyfXgwHV_gdXt8PvwG6xgjs
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEA6iiF7E91sjeK1Lk3SbHmVxWZ8XFbyVJE2lPtJFu-B68Lc7k7YrHhbBY_OAMJPJfOl8mSHkWMpcGqbAkIwxgQgtC1SY84CbjOmcC0xahGyLm-7gXlw8RA8zpNe-hUFaZXP212e6P62blk4jzc6wKDq3GNQDOBFhQEYITLs9J8B8sYzBydcPzwPwQ1SHEkSAw9v3c57kpTVYLaZBDfmJJ3mF0_zTNPzp_VB_mSw1AJKe1mtcITPWrZL5uqTkeJUs9NoKbmvk6XbsAN-9F5_gn6hyGfWPpfDjVblHhcUnaflRZJY65eD23JDkKABZasZVWUGnAZju5-IvfuSs0tGwUs-WFj8ZOkq3Tu77Z3e9QdDUVggMT6IqiLnUsdXKcNlVnutkkzwPBVO5TmQGAslVIqJQg1lalkFHlFmeaKUyZq0SfIPMutLZLUKZBlgjRSYxlTozoY5jzTHvHudGGMa3CW8lmpom8TjWv3hJW4bZU1rrIUU9YCvoYZsEk1nDOvHGH-PjVlnprw2Ugm_4Y-ZRq9sUFITSBAWUo3e8FmEUWEo5fQzzwVwAeTBms94Yk_UCOgqxNtjOv9d2SBYGd9dX6dX5zeUuWYQeUf__2SOz1dvI7gMiqvSB3_HfZrEI1w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synthesizing+and+staining+manganese+oxide+nanoparticles+for+cytotoxicity+and+cellular+uptake+investigation&rft.jtitle=Biochimica+et+biophysica+acta.+General+subjects&rft.au=Omid%2C+Hamed&rft.au=Oghabian%2C+Mohammad+Ali&rft.au=Ahmadi%2C+Reza&rft.au=Shahbazi%2C+Narges&rft.date=2014-01-01&rft.issn=0304-4165&rft.volume=1840+p.428-433&rft.spage=428&rft.epage=433&rft_id=info:doi/10.1016%2Fj.bbagen.2013.10.001&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-4165&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-4165&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-4165&client=summon